Gathering the Power of Authoritative Dermatology, Winona Baby Sets a Benchmark for Children's Cosmeceutical Products!

Gathering the Power of Authoritative Dermatology, Winona Baby Sets a Benchmark for Children's Cosmeceutical Products!

Children's health serves as a significant cornerstone of public health.

The "Healthy China 2030" Planning Outline calls for improving the services to ensure good prenatal and postnatal care, with explicit requirements for safeguarding children's health. Children's health is closely related to family happiness and the future of the nation. In October 2021, the National Health Commission issued the Healthy Children Action Promotion Plan (2021-2025) to guide localities to further improve children's health.

With the changes in economic development and living environment, people have noticed a qualitative shift in the skin of infants and young children. Factors such as genetics or environmental influences have led to a significant increase in children with sensitive skin issues. The focus on children's skin health has become a market priority, releasing substantial growth potential in this area.

Infants' skin shows significant differences from the skin of adults in terms of the stratum corneum, skin thickness, and tolerance levels. This is the underlying logic behind the need for more refined R&D of baby skincare products.

In 2022, the National Medical Products Administration issued an announcement on the Regulations on Supervision and Administration of Children's Cosmetics, emphasizing that the formula design of children's cosmetics should follow the three principles of "taking safety as a priority, regarding efficacy as the essential goal, and ensuring simplest formula." Subsequently, the Administration introduced the "Little Golden Shield" logo and other measures to continuously strengthen market supervision.

The Outline also requires efforts to be made from both the supply side and demand side to coordinate the three levels of society, industry and individuals, continuously improve institutional arrangements, and form a strong synergy to maintain and promote health. As a professional cosmeceutical brand for children in China, Winona Baby is also constantly practicing its corporate social responsibility.

To further promote creating a healthy skin ecosystem for children in China, provide authoritative skin care solutions and guidance for babies' skin in China, and promote the standardized development of the children's skincare industry, on April 21, 2023, the Child Skin Health Promotion Forum & Establishment Ceremony of the Chinese Expert Committee on Atopic Dermatitis in Children jointly organized by the Pediatric Dermatology Professional Committee of the Chinese Association for Improving Birth Outcome and Child Development and Winona Baby was officially launched in Shanghai.

The Chinese Expert Committee on Atopic Dermatitis in Children was initiated by dozens of authoritative experts in the field of dermatology, including Professor Liu Xiaoyan, Chairperson of the Pediatric Dermatology Professional Committee of the Chinese Association for Improving Birth Outcome and Child Development, Professor Ma Lin, Chairperson-designate of the Pediatric Dermatology Professional Committee of the Chinese Association for Improving Birth Outcome and Child Development, Professor He Li, Vice Chairwoman of the Asia-Pacific Skin Barrier Research Association and Vice Chairwoman of the Chinese Society of Dermatology.

Pursuing Academic Excellence, Winona Baby Cares About the Future of National Health

According to the research of relevant experts from the Pediatric Dermatology Professional Committee of the Chinese Association for Improving Birth Outcome and Child Development, infants and young children have a higher probability of skin diseases than adults due to incomplete epidermal barrier function, immature dermal fibrous structure, low melanocyte function, and imperfect secretion function of sebaceous glands and sweat glands of their skin. Among the many common skin diseases in children, the prevalence of atopic dermatitis (AD) is relatively high. Existing epidemiological studies have found the prevalence rate of AD in children aged 1-7 years in China is 12.94% and that in infants aged 1-12 months in the country reaches 30.48%.

AD is a non-fatal skin disease with the highest disease burden. The itching and skin lesions during AD outbreaks have a significant impact on the quality of life of patients, especially children. Controlling itching and clearing skin lesions are urgent treatment needs for many patients, so systematic treatment regimens are urgently needed.

Due to the late development of pediatric dermatology in China and a shortage of professional personnel, improving the effectiveness of systematic and standardized diagnosis and treatment for pediatric patients with AD, promoting long-term disease management for these children, enhancing care for them, and educating these children and their families are all challenges currently faced in pediatric dermatology clinical practice.

Winona Baby and authoritative dermatologists in China jointly promoted the organization of the Child Skin Health Promotion Forum & Establishment Ceremony of the Chinese Expert Committee on Atopic Dermatitis in Children, aiming to focus on the field of AD in children, promote the construction of pediatric dermatology in China, and create a platform for outstanding Chinese experts in the field of pediatric dermatology to carry out academic sharing and discussion on children's skin health issues.

Professor Ma Lin, Chairperson-designate of the Pediatric Dermatology Professional Committee of the Chinese Association for Improving Birth Outcome and Child Development

During the meeting, Professor Ma Lin shared her view on the topic of "Children's Skin Barrier and Management Strategies for Pediatric Skin Problems" and mentioned, "Due to genetic and environmental factors, Chinese babies have slower skin maturation compared with many foreign babies, making them more prone to skin diseases. Through clinical practice, it has been found that Winona Baby Soothing Hydrating Cream, when used as a routine moisturizer for children with AD during the remission period, can significantly reduce the risk of AD recurrence while maintaining treatment effects."

Professor He Li shared her opinion on the topic of "Research Progress of Children's Cosmeceutical Products" and stated, "Prinsepia utilis royle oil itself has a good barrier repair effect. Apart from barrier problems, AD also involves inflammatory reactions. Prinsepia utilis royle polysaccharides have a significant inhibitory effect on Cldn-1 in the granular layer and spinous layer."

Professor He Li, Vice Chairwoman of the Asia-Pacific Skin Barrier Research Association and Vice Chairwoman of the Chinese Society of Dermatology

In China, the health education system for children with AD lacks standardized expert guidelines, consensus, and opinions. There is a need for more breakthroughs, including health education content and steps and procedures before, during, and after diagnosis. The establishment of the Chinese Expert Committee on Atopic Dermatitis in Children can help standardize the diagnosis, treatment, and long-term management of pediatric AD, provide continuous care for pediatric AD patients, pay attention to the psychological health of their families, strengthen the education of children with AD, and jointly promote the standardization and regularization of child health clinics to enhance children's healthcare and medical services.

Dr. Guo Zhenyu, Chairman and President of Botanee Group

Long-term and standardized development cannot be separated from the support of enterprises. Dr. Guo Zhenyu, Chairman and President of Botanee Group, stated at the establishment ceremony of the Expert Committee, "Botanee is a responsible and social value-oriented enterprise. Through innovative collaboration among companies, universities, research institutes, and hospitals, and under the guidance of the Expert Committee, Winona Baby will continue to fulfill its corporate social responsibility and promote social welfare activities for baby skin health, hoping to provide authoritative skincare solutions for Chinese babies, set a new benchmark for the children's skincare industry in China and contribute to the implementation of the Healthy China Initiative." With the participation of Winona Baby, a leading Chinese cosmeceutical brand with cutting-edge consciousness and guiding principles that can continually understand consumers' skin needs and utilize advanced patented technology to continuously conduct product R&D and technological innovation, we can better drive the robust development of children's health in China and safeguard the future of society.

With the dual support of the Botanee Research Institute and the Yunnan Characteristic Plant Extraction Laboratory, Winona Baby conducts R&D based on clinical needs in dermatology. Starting from the mechanisms and action targets of pediatric dermatology, leveraging the Yunnan Characteristic Plant Resource Library, and utilizing the collaboration among companies, universities, research institutes, and hospitals, Winona Baby develops high-quality products to address the most critical and challenging issues in Chinese children's skin. This effort aims to promote children's skin health in China, lead the rise of baby skincare in China, and create a healthy skin ecosystem for Chinese babies.

Collaborative Innovation Among Companies, Universities, Research Institutes and Hospitals Leads the Rise of Baby Skincare in China

Winona Baby is a baby skincare brand established by Botanee Group in 2014. As the Group's second-largest core brand, Winona Baby achieved an impressive performance during last year's Double 11 shopping festival, ranking among the top 4 in Tmall's baby skincare category, making it a dark horse in the sector. With the continuous elevation of competition in the baby skincare market, Winona Baby's advantages in scientific research and innovation are increasingly evident.

Winona Baby is backed by Botanee, known as the "top 1 company of dermatological-grade skincare products," and Winona, the main brand for sensitive skin care. With profound brand accumulation and inheritance, Winona Baby's continuous brand potential is being fully unleashed.

Winona Baby has built a brand image of "professionally protecting babies with sensitive and vulnerable skin" on the consumer end and successfully created two popular products: Winona Baby Soothing Hydrating Cream and Winona Baby Mild Multicare Sunscreen.

The flagship product, Winona Baby Soothing Hydrating Cream, is considered a pinnacle in baby skincare in China, both in terms of mechanism and the effectiveness, safety, and experience validated in clinical trials. The brand has developed cosmeceutical products in collaboration with pediatric dermatology experts to address issues such as dryness, itching, and redness in baby skin, with the products containing the benchmark ingredient of Botanee Group—prinsepia utilis royle oil.

In Professor He Li's research on prinsepia utilis royle's reparative effect on children's skin barrier, she mentioned that the ingredient of prinsepia utilis royle can endogenously stimulate the baby's skin to produce more Ceramide 3, strengthening the barrier function from within. The ingredients of calendula and purslane can effectively alleviate various discomforts such as skin sensitivity and redness, providing internal protection against external skin irritation. In addition, sodium hyaluronate and Mushroom β-glucan help in long-term hydration and repair of the skin's moisture barrier.

In addition to the Winona Baby Soothing Hydrating Cream, the Winona Baby Mild Multicare Sunscreen is another popular product that deeply understands the demand in the baby sunscreen market. According to Tmall's data, among the current top 20 sunscreen brands in the market, 45% of brands offer exclusive sunscreen products for infants and young children. Consumers are most concerned about the safety, sun protection effectiveness, skin feeling, and ease of cleaning of children's sunscreen products.

Based on this, the Botanee Research Institute selected plant-based ingredients and dedicated three years to create the Winona Baby Mild Multicare Sunscreen, which has received a special certificate for children's sunscreen from the National Medical Products Administration. Winona Baby developed this sunscreen product specifically for sensitive baby skin, which has less melanin and is thinner. This product incorporates a safe protection concept and plant-based ingredients and has a sun protection factor of SPF50+ PA++++, offering 12.5 2 hours of sun protection and delaying skin tanning time by more than 16 3 times. It can effectively address outdoor UV exposure, providing a "protective umbrella" for the delicate skin of babies.

Winona Baby Mild Multicare Sunscreen

At the Winona Baby Satellite Seminar on the theme of sunscreen on April 23, Wang Shan, Deputy Chief Physician of the Dermatology Department at Beijing Children's Hospital affiliated with Capital Medical University, shared "the clinical research results on the efficacy of Mild Multicare Sunscreen containing calendula extract in improving skin symptoms after sun exposure."

Winona Baby Mild Multicare Sunscreen has already received the authoritative five-star safety certification from the German quality testing organization Dermatest after undergoing six major safety tests. Now, it has once again gained recognition from renowned domestic dermatologists, which reaffirms its efficacy and safety as a skincare product for infants and young children. What's more, Winona Baby is the first brand in China to conduct clinical efficacy testing for babies aged 0-2 years. Through rigorous scientific research and innovation practices, Winona Baby has propelled the scientificity and professionalism of children's skin health products in China to the forefront of the world. By addressing bottlenecks, the brand has truly enhanced the competitiveness of Chinese brands on the international stage and led the development of the baby skincare industry in China.

This time, Winona Baby supported the Child Skin Health Promotion Forum and promoted the establishment of the Chinese Expert Committee on Atopic Dermatitis in Children. The diagnosis, treatment, and care of children with AD in China will enter a new era of more precise, efficient, and standardized practices.

In the future, Winona Baby will continue its R&D collaboration with leading domestic pediatric dermatology centers, deepen academic cooperation with experts of the Committee, jointly implement the Healthy China Initiative, help promote the skin health of Chinese children, respond to the 14th Five-Year Plan for National Health issued by the State Council with practical actions, and create a healthy skin ecosystem for Chinese babies.

Data source: "Guideline for primary care of atopic dermatitis in children", [Guidelines for Primary Care of Common Diseases], Chinese Journal of General Practitioners. SPF50=15 minutes*50 times=750 minutes. The duration of sun protection should be determined based on the actual intensity of ultraviolet light. PA indicates the defense strength of sunscreen products against UVA rays. PA+ can delay the skin tanning time by 2-4 times, while PA++++ indicates a delay of more than 16 times.